ArticleJournal of pediatric gastroenterology and nutrition2026
Endoscopic bile duct stenting as preliminary treatment of complicated choledochal malformation before definitive surgery.
Article in Journal of pediatric gastroenterology and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Endoscopic bile duct stenting as preliminary treatment of complicated choledochal malformation before definitive surgery.Journal of pediatric gastroenterology and nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesAcute pancreatitis or obstruction is considered an indication for urgent surgery in patients with choledochal malformation. However, in this inflammatory stage, surgery can be challenging. Our approach is to treat the acute obstruction by endoscopic retrograde cholangiopancreatography (ERCP), papillotomy, and placement of a bile duct stent. Subsequently, surgical resection of choledochal malformation is performed after the inflammation has subsided.
methodsIn this retrospective study, we included all patients who underwent surgical resection in our department for choledochal malformation with prior ERCP between 12/2013 and 12/2024. Post-ERCP data of patients who received additional stenting were analyzed.
resultsTwenty patients (75% female) with a complicated choledochal malformation and a median age of 5.6 years (range 0.4-18.3 years) were included. Fourteen patients presented with biliary pancreatitis, six of these with an additional symptomatic cholelithiasis. Twelve patients with complicated choledochal malformation underwent papillotomy and stenting of the common bile duct with post-interventional clinical improvement. Out of these, three underwent a second and two patients a second and a third ERCP with stent replacement before surgery. One patient received six ECRPs in another hospital before surgery. After a median interval of 9 weeks after stenting (range, 2-34 weeks), three patients (25%) received open and nine (75%) laparoscopic resections of the choledochal malformation, with two conversions to open surgery (22%) due to massive adhesions. Surgery was uneventful in all patients.
conclusionOur data suggest that preoperative ERCP and stenting of the common bile duct is a valid option for patients with choledochal malformation complicated by pancreatitis or obstruction, making a laparoscopic approach feasible in the majority of patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.